FeesSafety
Pluang+

HF Foods to report Q3 2026 results on Nov 9 with a conference call scheduled.

Company Fundamentals
26 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
HF Foods to report Q3 2026 results on Nov 9 with a conference call scheduled.

HF Foods Group Inc., a distributor of Asian foodservice products in the US and Canada, will announce its financial results for the third quarter ended September 30, 2026, on November 9, 2026, after market close. The company will hold a conference call at 1:30 p.m. PT to discuss the results, which investors can join via webcast or phone. This update is important for stakeholders tracking HF Foods' performance amid its growth in the Asian American restaurant market.

HF Foods' upcoming Q3 2026 results announcement is noted here with a snapshot of the Consumer Staples sector on Pluang as of Oct 27, 2026 03:01 WIB. Among 63 US Consumer Staples stocks priced on Pluang, 23 advanced and 39 declined today. Notable movers include HRL (Hormel Foods Corp) up 4.16% at USD 21.29 with a typical hold time of 99 days, UL (Unilever plc) rising 3.99% at USD 66.97 with 62% sell order activity, and CHD (Church & Dwight Co., Inc.) increasing 3.53% at USD 108.71 with 100% sell order activity and a 55-day typical hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
24 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
24 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
36 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App